Skip to main content
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease logoLink to Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
. 2021 Mar 10;10(6):e014679. doi: 10.1161/JAHA.119.014679

Correction to: Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial

PMCID: PMC8174232  PMID: 33719497

In the article by Yun et al, “Safety of 3‐Month Dual Antiplatelet Therapy After Implantation of Ultrathin Sirolimus‐Eluting Stents With Biodegradable Polymer (Orsiro): Results From the SMART‐CHOICE Trial,” which published on December 21, 2020 and appeared in the January 5, 2021 issue of the Journal (J Am Heart Assoc. 2021;10:e018366. DOI: 10.1161/JAHA.120.018366), corrections were needed.

Two footnotes were inadvertently removed from the article during production:

*A complete list of the SMART‐CHOICE investigators can be found in the Appendix at the end of the manuscript.

Dr. Yun and Dr. Seung‐Yul Lee contributed equally to this work.

The publisher regrets the errors.

The footnotes have been added to the current online version of the article, which is available here: https://www.ahajournals.org/doi/10.1161/JAHA.120.018366

(J Am Heart Assoc. 2021;10:e014679. DOI: 10.1161/JAHA.119.014679.)


Articles from Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease are provided here courtesy of Wiley

RESOURCES